Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VABIP Study (Vaginal Biorevitalization With Polydeoxyribonucleotides) for the Improvement of the Genitourinary Syndrome of Menopause

NCT05464654 is registered in ClinicalTrials.gov with Hospital Regional 1o de Octubre as lead sponsor.

NCT NCT05464654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05464654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VABIP Study (Vaginal Biorevitalization With Polydeoxyribonucleotides) for the Improvement of the Genitourinary Syndrome of Menopause
Lead sponsor
Hospital Regional 1o de Octubre
Phase
Not applicable
Overall status
Completed
Start date
June 23, 2021
Completion date
December 31, 2022
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genitourinary syndrome of menopause, menopause, postmenopausal disorder, vagina atrophy